Literature DB >> 8386380

Structural basis for receptor subtype-specific regulation revealed by a chimeric beta 3/beta 2-adrenergic receptor.

S B Liggett1, N J Freedman, D A Schwinn, R J Lefkowitz.   

Abstract

The physiological significance of multiple G-protein-coupled receptor subtypes, such as the beta-adrenergic receptors (beta ARs), remains obscure, since in many cases several subtypes activate the same effector and utilize the same physiological agonists. We inspected the deduced amino acid sequences of the beta AR subtypes for variations in the determinants for agonist regulation as a potential basis for subtype differentiation. Whereas the beta 2AR has a C terminus containing 11 serine and threonine residues representing potential sites for beta AR kinase phosphorylation, which mediates rapid agonist-promoted desensitization, only 3 serines are present in the comparable region of the beta 3AR, and they are in a nonfavorable context. The beta 3AR also lacks sequence homology in regions which are important for agonist-mediated sequestration and down-regulation of the beta 2AR, although such determinants are less well defined. We therefore tested the idea that the agonist-induced regulatory properties of the two receptors might differ by expressing both subtypes in CHW cells and exposing them to the agonist isoproterenol. The beta 3AR did not display short-term agonist-promoted functional desensitization or sequestration, or long-term down-regulation. To assign a structural basis for these subtype-specific differences in agonist regulation, we constructed a chimeric beta 3/beta 2AR which comprised the beta 3AR up to proline-365 of the cytoplasmic tail and the C terminus of the beta 2AR. When cells expressing this chimeric beta 3/beta 2AR were exposed to isoproterenol, functional desensitization was observed. Whole-cell phosphorylation studies showed that the beta 2AR displayed agonist-dependent phosphorylation, but no such phosphorylation could be demonstrated with the beta 3AR, even when beta AR kinase was overexpressed. In contrast, the chimeric beta 3/beta 2AR did display agonist-dependent phosphorylation, consistent with its functional desensitization. In addition to conferring functional desensitization and phosphorylation to the beta 3AR, the C-terminal tail of the beta 2AR also conferred agonist-promoted sequestration and long-term receptor down-regulation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8386380      PMCID: PMC46362          DOI: 10.1073/pnas.90.8.3665

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Role of acidic amino acids in peptide substrates of the beta-adrenergic receptor kinase and rhodopsin kinase.

Authors:  J J Onorato; K Palczewski; J W Regan; M G Caron; R J Lefkowitz; J L Benovic
Journal:  Biochemistry       Date:  1991-05-28       Impact factor: 3.162

2.  Multiple pathways of rapid beta 2-adrenergic receptor desensitization. Delineation with specific inhibitors.

Authors:  M J Lohse; J L Benovic; M G Caron; R J Lefkowitz
Journal:  J Biol Chem       Date:  1990-02-25       Impact factor: 5.157

3.  Generation of protein-reactive antibodies by short peptides is an event of high frequency: implications for the structural basis of immune recognition.

Authors:  H L Niman; R A Houghten; L E Walker; R A Reisfeld; I A Wilson; J M Hogle; R A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

4.  Two distinct pathways for cAMP-mediated down-regulation of the beta 2-adrenergic receptor. Phosphorylation of the receptor and regulation of its mRNA level.

Authors:  M Bouvier; S Collins; B F O'Dowd; P T Campbell; A de Blasi; B K Kobilka; C MacGregor; G P Irons; M G Caron; R J Lefkowitz
Journal:  J Biol Chem       Date:  1989-10-05       Impact factor: 5.157

5.  Involvement of tyrosine residues located in the carboxyl tail of the human beta 2-adrenergic receptor in agonist-induced down-regulation of the receptor.

Authors:  M Valiquette; H Bonin; M Hnatowich; M G Caron; R J Lefkowitz; M Bouvier
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

6.  Beta-adrenergic receptor kinase: primary structure delineates a multigene family.

Authors:  J L Benovic; A DeBlasi; W C Stone; M G Caron; R J Lefkowitz
Journal:  Science       Date:  1989-10-13       Impact factor: 47.728

7.  Altered patterns of agonist-stimulated cAMP accumulation in cells expressing mutant beta 2-adrenergic receptors lacking phosphorylation sites.

Authors:  S B Liggett; M Bouvier; W P Hausdorff; B O'Dowd; M G Caron; R J Lefkowitz
Journal:  Mol Pharmacol       Date:  1989-10       Impact factor: 4.436

8.  Mutations of the human beta 2-adrenergic receptor that impair coupling to Gs interfere with receptor down-regulation but not sequestration.

Authors:  P T Campbell; M Hnatowich; B F O'Dowd; M G Caron; R J Lefkowitz; W P Hausdorff
Journal:  Mol Pharmacol       Date:  1991-02       Impact factor: 4.436

9.  A small region of the beta-adrenergic receptor is selectively involved in its rapid regulation.

Authors:  W P Hausdorff; P T Campbell; J Ostrowski; S S Yu; M G Caron; R J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

10.  Differential adrenergic regulation of beta 1- and beta 3-adrenoreceptor messenger ribonucleic acids in adipose tissues.

Authors:  J G Granneman; K N Lahners
Journal:  Endocrinology       Date:  1992-01       Impact factor: 4.736

View more
  60 in total

1.  Involvement of both G protein alphas and beta gamma subunits in beta-adrenergic stimulation of vascular L-type Ca(2+) channels.

Authors:  P Viard; N Macrez; C Mironneau; J Mironneau
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

Review 2.  Cardiac receptor physiology and its application to clinical imaging: present and future.

Authors:  H Tseng; J M Link; J R Stratton; J H Caldwell
Journal:  J Nucl Cardiol       Date:  2001 May-Jun       Impact factor: 5.952

3.  beta(3)-adrenoceptor deficiency blocks nitric oxide-dependent inhibition of myocardial contractility.

Authors:  P Varghese; R W Harrison; R A Lofthouse; D Georgakopoulos; D E Berkowitz; J M Hare
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

4.  The arrestin domain-containing 3 protein regulates body mass and energy expenditure.

Authors:  Parth Patwari; Valur Emilsson; Eric E Schadt; William A Chutkow; Samuel Lee; Alessandro Marsili; Yongzhao Zhang; Radu Dobrin; David E Cohen; P Reed Larsen; Ann Marie Zavacki; Loren G Fong; Stephen G Young; Richard T Lee
Journal:  Cell Metab       Date:  2011-10-06       Impact factor: 27.287

Review 5.  Once and future signaling: G protein-coupled receptor kinase control of neuronal sensitivity.

Authors:  Richard T Premont
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

Review 6.  [On the function of beta3-adrenoceptors in the human heart: signal transduction, inotropic effect and therapeutic prospects].

Authors:  Christian Pott; Dirk Steinritz; Andreas Napp; Wilhelm Bloch; Robert H G Schwinger; Klara Brixius
Journal:  Wien Med Wochenschr       Date:  2006-08

7.  Up-regulation and functional effect of cardiac β3-adrenoreceptors in alcoholic monkeys.

Authors:  Heng-Jie Cheng; Kathleen A Grant; Qing-Hua Han; James B Daunais; David P Friedman; Satoshi Masutani; William C Little; Che-Ping Cheng
Journal:  Alcohol Clin Exp Res       Date:  2010-05-12       Impact factor: 3.455

8.  The function of alpha- and beta-adrenoceptors of the saphenous artery in caveolin-1 knockout and wild-type mice.

Authors:  S Neidhold; B Eichhorn; M Kasper; U Ravens; A J Kaumann
Journal:  Br J Pharmacol       Date:  2006-12-18       Impact factor: 8.739

9.  Alternative splicing generates two isoforms of the beta3-adrenoceptor which are differentially expressed in mouse tissues.

Authors:  B A Evans; M Papaioannou; S Hamilton; R J Summers
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

10.  Persistent Catechol-O-methyltransferase-dependent Pain Is Initiated by Peripheral β-Adrenergic Receptors.

Authors:  Brittney P Ciszek; Sandra C O'Buckley; Andrea G Nackley
Journal:  Anesthesiology       Date:  2016-05       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.